These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 31761524)

  • 21. Examining the reliability and validity of the Clinical Assessment Interview for Negative Symptoms within the Management of Schizophrenia in Clinical Practice (MOSAIC) multisite national study.
    Blanchard JJ; Bradshaw KR; Garcia CP; Nasrallah HA; Harvey PD; Casey D; Csoboth CT; Hudson JI; Julian L; Lentz E; Nuechterlein KH; Perkins DO; Skale TG; Snowden LR; Tandon R; Tek C; Velligan D; Vinogradov S; O'Gorman C
    Schizophr Res; 2017 Jul; 185():137-143. PubMed ID: 28087270
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A positive take on schizophrenia negative symptom scales: Converting scores between the SANS, NSA and SDS.
    Preda A; Nguyen DD; Bustillo JR; Belger A; O'Leary DS; McEwen S; Ling S; Faziola L; Mathalon DH; Ford JM; Potkin SG; ; van Erp TGM
    Schizophr Res; 2018 Nov; 201():113-119. PubMed ID: 29935887
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reliability and validity of a brief self-rated scale of health condition with acute schizophrenia.
    Ohata H; Yotsumoto K; Taira M; Kochi Y; Hashimoto T
    Psychiatry Clin Neurosci; 2014 Jan; 68(1):70-7. PubMed ID: 24171726
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnostic validity of assessment scales for depression in patients with schizophrenia.
    Kim SW; Kim SJ; Yoon BH; Kim JM; Shin IS; Hwang MY; Yoon JS
    Psychiatry Res; 2006 Sep; 144(1):57-63. PubMed ID: 16904189
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical utility of the Calgary Depression Scale for Schizophrenia in individuals at ultra-high risk of psychosis.
    Rekhi G; Ng WY; Lee J
    Schizophr Res; 2018 Mar; 193():423-427. PubMed ID: 28712967
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association between changes on the Negative Symptom Assessment scale (NSA-16) and measures of functional outcome in schizophrenia.
    Velligan DI; Alphs L; Lancaster S; Morlock R; Mintz J
    Psychiatry Res; 2009 Sep; 169(2):97-100. PubMed ID: 19664826
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of auditory hallucinations in patients with schizophrenia: A validation study of the Malay version of Psychotic Symptom Rating Scales (PSYRATS).
    Wahab S; Zakaria MN; Sidek D; Abdul Rahman AH; Shah SA; Abdul Wahab NA
    Psychiatry Res; 2015 Aug; 228(3):462-7. PubMed ID: 26142835
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An Assessment of Five (PANSS, SAPS, SANS, NSA-16, CGI-SCH) commonly used Symptoms Rating Scales in Schizophrenia and Comparison to Newer Scales (CAINS, BNSS).
    Kumari S; Malik M; Florival C; Manalai P; Sonje S
    J Addict Res Ther; 2017; 8(3):. PubMed ID: 29430333
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Yoruba version of the Beck Hopelessness Scale: psychometric characteristics and correlates of hopelessness in a sample of Nigerian psychiatric outpatients.
    Aloba O; Akinsulore A; Mapayi B; Oloniniyi I; Mosaku K; Alimi T; Esan O
    Compr Psychiatry; 2015 Jan; 56():258-71. PubMed ID: 25446724
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Guilt and depression: two different factors in individuals with negative symptoms of schizophrenia.
    Rabany L; Weiser M; Levkovitz Y
    Eur Psychiatry; 2013 Aug; 28(6):327-31. PubMed ID: 23021933
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Calgary Depression Rating Scale for schizophrenia in a healthy control group: psychometric properties and reference values.
    Müller MJ; Brening H; Gensch C; Klinga J; Kienzle B; Müller KM
    J Affect Disord; 2005 Sep; 88(1):69-74. PubMed ID: 16040126
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relationship of depression with cognitive insight and socio-occupational outcome in patients with schizophrenia.
    Grover S; Sahoo S; Nehra R; Chakrabarti S; Avasthi A
    Int J Soc Psychiatry; 2017 May; 63(3):181-194. PubMed ID: 28162014
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Brief Negative Symptom Scale: Validation in a multicenter Brazilian study.
    de Medeiros HLV; Vasconcelos SC; Elkis H; Martins DR; de Alexandria Leite RM; de Albuquerque ACL; Freitas RR; Scardoelli MA; Di Sarno E; Napolitano I; Oliveira GM; Vizzotto A; da Silva AMP; da Costa Lima MD
    Compr Psychiatry; 2018 Aug; 85():42-47. PubMed ID: 29966891
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Validation of the traditional script Chinese version of the brief negative symptom scale.
    Sun J; Ching EWK; Strauss GP; Ahmed AO; Chui WWH; Chow JSY
    Asian J Psychiatr; 2021 Jan; 55():102522. PubMed ID: 33360707
    [TBL] [Abstract][Full Text] [Related]  

  • 35. What are depressive symptoms in acutely ill patients with schizophrenia spectrum disorder?
    Schennach R; Riedel M; Obermeier M; Seemüller F; Jäger M; Schmauss M; Laux G; Pfeiffer H; Naber D; Schmidt LG; Gaebel W; Klosterkötter J; Heuser I; Maier W; Lemke MR; Rüther E; Klingberg S; Gastpar M; Möller HJ
    Eur Psychiatry; 2015 Jan; 30(1):43-50. PubMed ID: 25541347
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Self-assessment of negative symptoms - Critical appraisal of the motivation and pleasure - Self-report's (MAP-SR) validity and reliability.
    Richter J; Hesse K; Eberle MC; Eckstein KN; Zimmermann L; Schreiber L; Burmeister CP; Wildgruber D; Klingberg S
    Compr Psychiatry; 2019 Jan; 88():22-28. PubMed ID: 30466014
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of depression in schizophrenia: psychometric properties of a French version of the Calgary Depression Scale.
    Lançon C; Auquier P; Reine G; Toumi M; Addington D
    Psychiatry Res; 1999 Dec; 89(2):123-32. PubMed ID: 10646831
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Calgary Depression Scale for Schizophrenia: a study of the validity of a French-language version in a population of schizophrenic patients.
    Bernard D; Lançon C; Auquier P; Reine G; Addington D
    Acta Psychiatr Scand; 1998 Jan; 97(1):36-41. PubMed ID: 9504701
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Specificity of the Calgary Depression Scale for schizophrenics.
    Addington D; Addington J; Maticka-Tyndale E
    Schizophr Res; 1994 Feb; 11(3):239-44. PubMed ID: 8193062
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Validity study of the Brazilian version of the Calgary Depression Scale for Schizophrenia.
    Bressan RA; Chaves AC; Shirakawa I; de Mari J
    Schizophr Res; 1998 Jun; 32(1):41-9. PubMed ID: 9690333
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.